Latest Papers In the Pancreatic Cancer Genomics Group

Here are the latest updates to Pancreatic Cancer Genomics Group in Mendeley.  These additions included some great contributions from researchers at the Sol Goldman Institute for Pancreatic Cancer at Johns Hopkins.  There’s also some promising news from the Von Hoff team at TGen on their gemcitabine + nab-paclitaxel trial.


About Mark Fortner

I write software for scientists doing drug discovery and cancer research. I'm interested in Design Thinking, Agile Software Development, Web Components, Java, Javascript, Groovy, Grails, MongoDB, Firebase, microservices, the Semantic Web Drug Discovery and Cancer Biology.
This entry was posted in pancreatic cancer and tagged , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s